Influence of endogenous corticosteroids on bronchial protective properties of β2 -agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
The inhaled PDE4 inhibitor UK-500,001 does not significantly inhibit airway responses to allergen and histamine Source: Annual Congress 2007 - New drugs for asthma Year: 2007
Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Source: Eur Respir J 2002; 20: 853-858 Year: 2002
Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma Source: Eur Respir J 2003; 21: 1046-1049 Year: 2003
Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma Source: Eur Respir J 2009; 33: 1277-1286 Year: 2009
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006
Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity Source: Eur Respir J 2005; 25: 864-872 Year: 2005
Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma Source: Eur Respir J 2002; 20: Suppl. 38, 471s Year: 2002
Role of target-cells sensitivity to corticosteroids in cold bronchial hyperresponsiveness development Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011
Cough during airway challenges: associations with bronchoconstriction and asthma Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Changes in objective markers following inhaled corticosteroids (ICS) in asthmatics with airway hyperresponsiveness (AHR) to mannitol Source: International Congress 2019 – Airway physiology Year: 2019
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009
Effect of drug delivery and receptor affinity on airway hyperresponsiveness in asthma Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006